BioCatalystWatch
RNAWorkspace / RNA / OverviewCompany library
Atrium Therapeutics, Inc. logo

Atrium Therapeutics, Inc.

Atrium Therapeutics, Inc. (RNA)

Website

Price
Market cap
Next catalystExpected 2H 2027ATR 1072 — Corventis · Phase 1/2 dataCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

ATR 1072

Mutant PRKAG2 mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

ATR 1072

Mutant PRKAG2 mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

ATR 1086

PLN mRNA

Upcoming / outlook

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

RNA PR & News

PR & News

RNA SEC archive